133 related articles for article (PubMed ID: 9816258)
21. Therapeutic efficacy and bone marrow protection of the mdr1 gene and over-dose chemotherapy with doxorubicin for rabbits with VX2 hepatocarcinoma.
Wang Y; Jin XQ; Wang S; Wang Q; Luo Q; Luo XJ
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):545-51. PubMed ID: 17085340
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells.
Aksentijevich I; Pastan I; Lunardi-Iskandar Y; Gallo RC; Gottesman MM; Thierry AR
Hum Gene Ther; 1996 Jun; 7(9):1111-22. PubMed ID: 8773513
[TBL] [Abstract][Full Text] [Related]
23. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
24. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
[TBL] [Abstract][Full Text] [Related]
25. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
26. In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate.
Mitsuhashi J; Hosoyama H; Tsukahara S; Katayama K; Noguchi K; Ito Y; Hatake K; Aiba K; Takahashi S; Sugimoto Y
J Gene Med; 2010 Jul; 12(7):596-603. PubMed ID: 20533531
[TBL] [Abstract][Full Text] [Related]
27. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D
Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634
[TBL] [Abstract][Full Text] [Related]
28. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
[TBL] [Abstract][Full Text] [Related]
29. Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance.
Koç ON; Allay JA; Lee K; Davis BM; Reese JS; Gerson SL
Semin Oncol; 1996 Feb; 23(1):46-65. PubMed ID: 8607032
[TBL] [Abstract][Full Text] [Related]
30. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.
Wang J; Chen Z; Xia X; Lu D; Xue J; Ruan C
Chin Med J (Engl); 2001 Jan; 114(1):25-9. PubMed ID: 11779430
[TBL] [Abstract][Full Text] [Related]
31. Retroviral transfer of the multidrug resistance-1 gene into lineage-committed and primitive hemopoietic cells.
Fruehauf S; Boesen JJ; Breems DA; Höft R; Hundsdörfer P; Zeller WJ; Löwenberg B; Ploemacher RE; Haas R; Valerio D
Stem Cells; 1995 Dec; 13 Suppl 3():93-9. PubMed ID: 8747995
[TBL] [Abstract][Full Text] [Related]
32. [Chemoprotection of transfer of multidrug resistance gene into human hematopoietic progenitor cell].
Pan L; Tong Y; Zhou S; Wu Y; Mao N; Yang X
Chin Med J (Engl); 2000 Jun; 113(6):536-9. PubMed ID: 11775875
[TBL] [Abstract][Full Text] [Related]
33. Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer.
Cmejlova J; Hildinger M; Cmejla R; Fuchs O; Kalabova D; Baum C; Jelinek J
Gene Ther; 2003 Jun; 10(12):1061-5. PubMed ID: 12776165
[TBL] [Abstract][Full Text] [Related]
34. Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide.
Fairbairn LJ; Chinnasamy N; Lashford LS; Chinnasamy D; Rafferty JA
Cancer Gene Ther; 2000 Feb; 7(2):233-9. PubMed ID: 10770631
[TBL] [Abstract][Full Text] [Related]
35. Treatment of multidrug-resistant murine leukemia with antisense mdr1 oligodeoxynucleotides.
Hiratake S; Azuma E; Nishiguchi Y; Nagai M; Ido M; Komada Y; Sakurai M
Biomed Pharmacother; 1997; 51(6-7):276-83. PubMed ID: 9309248
[TBL] [Abstract][Full Text] [Related]
36. Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer.
Tian C; Bagley J; Kaye J; Iacomini J
J Gene Med; 2003 May; 5(5):359-65. PubMed ID: 12731084
[TBL] [Abstract][Full Text] [Related]
37. Retroviral transfer of human MDR1 gene to hematopoietic cells: effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein.
Licht T; Aran JM; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
Hum Gene Ther; 1999 Sep; 10(13):2173-85. PubMed ID: 10498249
[TBL] [Abstract][Full Text] [Related]
38. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase.
Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D
Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145
[TBL] [Abstract][Full Text] [Related]
39. [Gene therapy using anticancer drug-resistance genes].
Sugimoto Y
Hum Cell; 1999 Sep; 12(3):115-23. PubMed ID: 10695018
[TBL] [Abstract][Full Text] [Related]
40. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]